The pharmaceutical with the highest sales value in Norway in 2021 was Hyrimoz, a biosimilar of Humira (adalimumab), with a sales value of 907 million Norwegian kroner. Merck & Co.'s Keytruda (pembrolizumab) followed, with a sales value of 844 million Norwegian kroner.
Leading pharmaceuticals in Norway based on sales in 2021
(in million NOK)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Legemiddelindustrien. (March 14, 2022). Leading pharmaceuticals in Norway based on sales in 2021 (in million NOK) [Graph]. In Statista. Retrieved August 13, 2022, from https://www.statista.com/statistics/949379/top-prescription-drugs-sold-in-norway-by-value/
Legemiddelindustrien. "Leading pharmaceuticals in Norway based on sales in 2021 (in million NOK) ." Chart. March 14, 2022. Statista. Accessed August 13, 2022. https://www.statista.com/statistics/949379/top-prescription-drugs-sold-in-norway-by-value/
Legemiddelindustrien. (2022). Leading pharmaceuticals in Norway based on sales in 2021 (in million NOK) . Statista. Statista Inc.. Accessed: August 13, 2022. https://www.statista.com/statistics/949379/top-prescription-drugs-sold-in-norway-by-value/
Legemiddelindustrien. "Leading Pharmaceuticals in Norway Based on Sales in 2021 (in Million Nok) ." Statista, Statista Inc., 14 Mar 2022, https://www.statista.com/statistics/949379/top-prescription-drugs-sold-in-norway-by-value/
Legemiddelindustrien, Leading pharmaceuticals in Norway based on sales in 2021 (in million NOK) Statista, https://www.statista.com/statistics/949379/top-prescription-drugs-sold-in-norway-by-value/ (last visited August 13, 2022)
